Imperva Announces Second Quarter 2013 Financial Results
Imperva Announces Second Quarter 2013 Financial Results
Total revenue of $31.3 million during the second quarter, up 28% year-over-year
Second quarter services revenue growth of 49% was driven by the 156% year-over-year increase in subscription revenue
New customers increased 46% year-over-year to 185 during the second quarter
The number of deals valued over $100,000 up 36% year-over-year
Total deferred revenue at June 30, 2013 increased 32% year-over-year to $48.3 million
REDWOOD SHORES, Calif.--(BUSINESS WIRE)-- Imperva, Inc. (NYS: IMPV) , a pioneer and leader of a new category of business security solutions for critical applications and high-value data in the data center, today announced financial results for the second quarter ended June 30, 2013.
"The second quarter was highlighted by the 46% year-over-year growth in new customers and 36% increase in deals valued over $100,000," stated Shlomo Kramer, President and Chief Executive Officer of Imperva. "While we continued to see strong demand for our fully integrated solution, performance in Europe and South America was impacted by sales execution challenges in these regions. Looking forward, we have already taken steps to reaccelerate growth and remain confident in our ability to grow global market share due to the continued strong pipeline of opportunities worldwide."
Second Quarter 2013 Financial Highlights
Revenue: Total revenue for the second quarter of 2013 was $31.3 million, an increase of 28% compared to $24.6 million in the second quarter of 2012. Within total revenue, product revenue was $15.7 million compared to $14.0 million during the second quarter of 2012. Services revenue increased 49% year-over-year to $15.7 million and accounted for 50% of total revenue, up from 43% in the second quarter of 2012. Within services revenue, overall subscription revenue grew 156%, to $2.5 million, compared to the second quarter of 2012. Combined product and subscriptions revenue, a leading indicator of the strength of our business, was $18.2 million compared to $15.0 million during the second quarter of 2012.
Operating Profit (Loss): Operating loss as reported in accordance with U.S. generally accepted accounting principles (GAAP) was $(5.7) million for the second quarter compared to a loss of $(1.4) million during the second quarter in 2012. GAAP results included stock-based compensation expense of $3.6 million for the second quarter of 2013 and $1.2 million for the second quarter of 2012. Non-GAAP operating loss for the second quarter was $(2.1) million, compared to a loss of $(0.3) million during the same period in 2012, excluding the above mentioned charges.
Net Profit (Loss): GAAP net loss attributable to Imperva stockholders for the second quarter was $(5.9) million, or $(0.24) per share based on 24.2 million weighted average diluted shares outstanding. This compares to GAAP net loss attributable to Imperva stockholders of $(1.5) million, or $(0.07) per share based on 22.6 million weighted average shares outstanding in the prior-year period.
Non-GAAP net loss attributable to Imperva stockholders for the second quarter of 2013 was $(2.3) million, or $(0.10) per share based on 24.2 million weighted average diluted shares outstanding, excluding the above mentioned charges. This compares to non-GAAP net loss attributable to Imperva stockholders of $(0.4) million, or $(0.02) per share based on 22.6 million weighted average diluted shares outstanding in the prior-year period.
Both GAAP and non-GAAP profit and loss per share attributable to Imperva stockholders for the second quarter ended June 30, 2013 adjust for the loss attributable to Imperva's non-controlling interest in Incapsula.
Balance Sheet: As of June 30, 2013, Imperva had cash, cash equivalents and investments of $110.4 million. Total deferred revenue of $48.3 million increased 32% compared to $36.5 million as of June 30, 2012.
Second Quarter and Recent Operating Highlights
During the second quarter of 2013, Imperva added 185 new customers, up 46% compared to the second quarter of last year. Imperva now has over 2,600 customers in more than 75 countries around the world.
During the second quarter of 2013, Imperva booked 76 deals with a value over $100,000, an increase of 36% compared to 56 deals in the second quarter of last year.
Business Outlook
The following forward-looking statements reflect expectations as of August 7, 2013. Results may be materially different and could be affected by the factors detailed in this press release and in recent Imperva SEC filings.
Third Quarter Expectations - Ending September 30, 2013
Imperva expects total revenue for the third quarter of 2013 to be in the range of $34.0 million to $35.0 million, representing growth in the range of 29% to 33% compared to the same period in 2012. The company expects in the third quarter of 2013 non-GAAP gross margins of approximately 80%. Further, Imperva expects in the third quarter of 2013 non-GAAP operating loss to be in the range of $(0.5) million to $(1.0) million and non-GAAP net loss attributable to Imperva stockholders to be in the range of $(1.0) million to $(1.5) million, or a loss of $(0.04) to $(0.06) per share, which excludes stock-based compensation expense.
Full Year Expectations -Ending December 31, 2013
Imperva expects total revenue for 2013 to be in the range of $135.0 million to $137.0 million, or up 30% to 31% compared to 2012. Imperva expects 2013 non-GAAP gross margins of approximately 80%. Further, the company expects 2013 non-GAAP operating loss to be in the range of $(1.5) million to $(2.5) million and non-GAAP net loss attributable to Imperva stockholders to be in the range of $(2.0) million to $(3.0) million, or a loss of $(0.06) to $(0.10) per share, which excludes stock-based compensation expense. Imperva expects capital expenditures for the full year to be in the range of $2.5 million to $3.5 million. Finally, the company expects to continue to generate positive cash flows from operations in 2013.
Quarterly Conference Call
Imperva will host a conference call today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to review the company's financial results for the second quarter ended June 30, 2013. To access this call, dial 888.293.6960 for the U.S. and Canada or 719.457.2716 for international callers with conference ID #6020963. A live webcast of the conference call will be accessible from the investors page of Imperva's website at www.imperva.com, and a recording will be archived and accessible at www.imperva.com. An audio replay of this conference call will also be available through August 21, 2013, by dialing 877.870.5176 for the U.S. and Canada, or 858.384.5517 for international callers and entering passcode #6020963.
Non-GAAP Financial Measures
Imperva reports all financial information required in accordance with U.S. generally accepted accounting principles (GAAP). To supplement the Imperva unaudited condensed consolidated financial statements presented in accordance with GAAP, Imperva uses certain non-GAAP measures of financial performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from, as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the results of Imperva operations as determined in accordance with GAAP. The non-GAAP financial measures used by Imperva include historical non-GAAP net loss and non-GAAP basic and diluted loss per share. These non-GAAP financial measures exclude stock-based compensation from the Imperva unaudited condensed consolidated statement of operations.
For a description of these items, including the reasons why management adjusts for them, and reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures, please see the section of the accompanying tables titled "Use of Non-GAAP Financial Information" as well as the related tables that precede it. Imperva may consider whether other significant non-recurring items that arise in the future should also be excluded in calculating the non-GAAP financial measures it uses.
Imperva believes that these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provide meaningful supplemental information regarding the performance of Imperva by excluding certain items that may not be indicative of the company's core business, operating results or future outlook. Imperva management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing operating results of Imperva, as well as when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate comparisons of the performance of Imperva to prior periods.
Forward Looking Statements
This press release contains forward-looking statements, including without limitation those regarding Imperva's "Business Outlook" ("Third Quarter Expectations - Ending September 30, 2013" and "Full Year Expectations - Ending December 31, 2013"); Imperva's belief that the steps it has taken, including to address sales execution challenges in Europe and South America, will result in reacceleration of growth in these regions; and Imperva's belief that the worldwide pipeline of opportunities will enable it to grow global market share. These forward-looking statements are subject to material risks and uncertainties that may cause actual results to differ substantially from expectations. Investors should consider important risk factors, which include: the risk that demand for our business security solutions may not increase and may decrease; the risk that we may not timely introduce new products or versions of our products and that they may not be accepted by the market; the risk that competitors may be perceived by customers to be better positioned to help handle business security threats and protect their businesses from major risk; the risk that the growth of Imperva may be lower than anticipated; and other risks detailed under the caption "Risk Factors" in the company's Form 10-Q filed with the Securities and Exchange Commission, or the SEC, on May 9, 2013 and the company's other SEC filings. You can obtain copies of the company's SEC filings on the SEC's website at www.sec.gov.
The foregoing information represents the company's outlook only as of the date of this press release, and Imperva undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, new developments or otherwise.
About Imperva
Imperva is a pioneer and leader of a new category of business security solutions for critical applications and high-value data in the data center. Imperva's award-winning solutions protect against data theft, insider abuse, and fraud while streamlining regulatory compliance by monitoring and controlling data usage and business transactions across the data center, from storage in a database or on a file server to consumption through applications. With over 2,600 end-user customers in more than 75 countries and thousands of organizations protected through cloud-based deployments, securing your business with Imperva puts you in the company of the world's leading organizations. For more information, visit www.imperva.com, follow us on Twitter or visit our blog.
© 2013 Imperva, Inc. All rights reserved. Imperva and the Imperva logo are trademarks of Imperva, Inc.
IMPERVA, INC. AND SUBSIDIARIES | ||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||
(On a GAAP basis) | ||||||||||||
(In thousands, except per share amounts) | ||||||||||||
(Unaudited) | ||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||
June 30, | June 30, | June 30, | June 30, | |||||||||
2013 | 2012 | 2013 | 2012 | |||||||||
Net revenue: | ||||||||||||
Products and license | $ | 15,671 | $ | 14,044 | $ | 29,825 | $ | 26,096 | ||||
Services | 15,668 | 10,510 | 30,099 | 19,976 | ||||||||
Total net revenue | 31,339 | 24,554 | 59,924 | 46,072 | ||||||||
Cost of revenue(1): | ||||||||||||
Products and license | 2,446 | 2,274 | 4,322 | 4,128 | ||||||||
Services and support | 5,098 | 3,139 | 9,513 | 5,872 | ||||||||
Total cost of revenue | 7,544 | 5,413 | 13,835 | 10,000 | ||||||||
Gross profit | 23,795 | 19,141 | 46,089 | 36,072 | ||||||||
Operating expenses(1): | ||||||||||||
Research and development | 6,646 | 4,925 | 13,004 | 9,918 | ||||||||
Sales and marketing | 18,281 | 11,926 | 35,828 | 23,522 | ||||||||
General and administrative | 4,597 | 3,739 | 8,980 | 7,232 | ||||||||
Total operating expenses | 29,524 | 20,590 | 57,812 | 40,672 | ||||||||
Loss from operations | (5,729) | (1,449) | (11,723) | (4,600) | ||||||||
Other expense, net | (55) | 11 | (102) | (59) | ||||||||
Loss before provision for income taxes | (5,784) | (1,438) | (11,825) | (4,659) | ||||||||
Provision for income taxes | 261 | 227 | 415 | 380 | ||||||||
Net loss | (6,045) | (1,665) | (12,240) | (5,039) | ||||||||
Add: Loss attributable to noncontrolling interest | 130 | 132 | 266 | 235 | ||||||||
Net loss attributable to Imperva, Inc. stockholders | $ | (5,915) | $ | (1,533) | $ | (11,974) | $ | (4,804) | ||||
Net loss per share of common stock attributable to | ||||||||||||
Imperva, Inc. stockholders, basic and diluted | $ | (0.24) | $ | (0.07) | $ | (0.50) | $ | (0.21) | ||||
Shares used in computing net loss per share of | ||||||||||||
common stock, basic and diluted | 24,171 | 22,583 | 24,039 | 22,443 | ||||||||
(1) Stock-based compensation expense as included in above: | ||||||||||||
Cost of revenue | $ | 255 | $ | 104 | $ | 468 | $ | 159 | ||||
Research and development | 720 | 260 | 1,386 | 387 | ||||||||
Sales and marketing | 1,643 | 439 | 2,976 | 700 | ||||||||
General and administrative | 974 | 363 | 1,615 | 588 | ||||||||
Total stock-based compensation expense | $ | 3,592 | $ | 1,166 | $ | 6,445 | $ | 1,834 | ||||
IMPERVA, INC. AND SUBSIDIARIES | ||||||
Condensed Consolidated Balance Sheets | ||||||
(In thousands) | ||||||
(Unaudited) | ||||||
As of | As of | |||||
June 30, | December 31, | |||||
2013 | 2012 | |||||
Assets | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | 70,021 | $ | 59,201 | ||
Short-term investments | 40,362 | 43,126 | ||||
Restricted cash, current | 33 | 591 | ||||
Accounts receivable, net | 27,087 | 35,576 | ||||
Inventory | 368 | 328 | ||||
Deferred tax assets | 615 | 597 | ||||
Prepaid expenses and other current assets | 4,663 | 4,356 | ||||
Total current assets | 143,149 | 143,775 | ||||
Property and equipment, net | 5,448 | 5,515 | ||||
Severance pay fund | 3,535 | 3,150 | ||||
Restricted cash | 1,252 | 753 | ||||
Other assets | 772 | 764 | ||||
Total assets | $ | 154,156 | $ | 153,957 | ||
Liabilities and stockholders' equity | ||||||
Current liabilities: | ||||||
Accounts payable | $ | 3,773 | $ | 3,789 | ||
Accrued compensation and benefits | 10,608 | 9,258 | ||||
Accrued and other current liabilities | 3,822 | 4,323 | ||||
Deferred revenue | 33,826 | 33,609 | ||||
Total current liabilities | 52,029 | 50,979 | ||||
Other liabilities | 2,349 | 2,638 | ||||
Deferred revenue | 14,477 | 12,682 | ||||
Accrued severance pay | 3,877 | 3,427 | ||||
Total liabilities | 72,732 | 69,726 | ||||
Stockholders' equity: | ||||||
Common stock | 2 | 2 | ||||
Additional paid-in capital | 167,764 | 157,989 | ||||
Accumulated deficit | (85,491) | (73,517) | ||||
Accumulated other comprehensive income (loss) | 556 | 861 | ||||
Total Imperva, Inc. stockholders' equity | 82,831 | 85,335 | ||||
Noncontrolling interest | (1,407) | (1,104) | ||||
Total stockholders' equity | 81,424 | 84,231 | ||||
Total liabilities and stockholders' equity | $ | 154,156 | $ | 153,957 | ||
IMPERVA, INC. AND SUBSIDIARIES | ||||||
Condensed Consolidated Statements of Cash Flows | ||||||
(In thousands) | ||||||
(Unaudited) | ||||||
For the Six Months Ended | ||||||
June 30, | June 30, | |||||
2013 | 2012 | |||||
Cash flows from operating activities: | ||||||
Net loss | $ | (12,240) | $ | (5,039) | ||
Adjustments to reconcile net loss to net cash provided by | ||||||
Depreciation and amortization | 1,269 | 850 | ||||
Stock-based compensation | 6,445 | 1,834 | ||||
Amortization of premiums/accretion of discounts | 383 | 197 | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 8,489 | 2,548 | ||||
Inventory | (40) | 59 | ||||
Prepaid expenses and other assets | (404) | (793) | ||||
Accounts payable | (16) | (1,114) | ||||
Accrued compensation and benefits | 1,350 | 966 | ||||
Accrued and other liabilities | (390) | (496) | ||||
Severance pay, net | 65 | 301 | ||||
Deferred revenue | 2,012 | 3,548 | ||||
Deferred tax assets | (18) | - | ||||
